Table 5.
Univariable and multivariable logistic regression analysis for ABMR/MVI development according to HLA and non-HLA antibodies after KT, at biopsy time.
| OR | p-Value | CI (95%) | |
|---|---|---|---|
| Univariable | |||
| Recipient sex (female) | 2.932 | 0.006 | 1.372–6.265 |
| Recipient age (years) | 0.993 | 0.634 | 0.966–1.021 |
| Body mass index (kg/m2) | 1.005 | 0.873 | 0.942–1.072 |
| Cause of end-stage renal disease (immune mediated) | 0.917 | 0.860 | 0.352–2.392 |
| Preemptive KT | 1.503 | 0.463 | 0.506–4.464 |
| Median time on dialysis (months) | 1.003 | 0.703 | 0.987–1.019 |
| Donor age (years) | 0.992 | 0.565 | 0.967–1.018 |
| Donor type (live donor) | 1.024 | 0.958 | 0.420–2.500 |
| Median cold ischemia time (h) | 1.016 | 0.591 | 0.959–1.076 |
| HLA-DSA after KT | 24.000 | <0.001 | 6.597–87.315 |
| Non-HLA MFI ratio after KT | 1.039 | 0.006 | 1.011–1.067 |
| Extracellular non-HLA MFI ratio sum after KT | 1.060 | 0.015 | 1.011–1.111 |
| Intracellular non-HLA MFI ratio sum after KT | 1.075 | 0.002 | 1.027–1.126 |
| A. Multivariable, non-HLA as MFI ratio sum | |||
| HLA-DSA after KT | 24.752 | <0.001 | 6.352–96.355 |
| Non-HLA MFI ratio after KT | 1.031 | 0.035 | 1.002–1.060 |
| Recipient sex (female) | 3.399 | 0.011 | 1.317–8.769 |
| B. Multivariable, non-HLA as extracellular MFI ratio sum | |||
| HLA-DSA after KT | 24.984 | <0.001 | 6.462–96.599 |
| Extracellular non-HLA MFI ratio sum after KT | 1.050 | 0.062 | 0.998–1.106 |
| Recipient sex (female) | 3.392 | 0.011 | 1.326–8.675 |
| C. Multivariable, non-HLA as intracellular MFI ratio sum | |||
| HLA-DSA after KT | 25.027 | <0.001 | 6.426–97.631 |
| Intracellular non-HLA MFI ratio sum after KT | 1.062 | 0.018 | 1.011–1.116 |
| Recipient sex (female) | 3.074 | 0.021 | 1.186–7.964 |